Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism

Green, Katrina; Huang, Xu-Feng; Kang, K; Deng, Chao

Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism

journal contribution

posted on 2024-11-14, 18:51 authored by Katrina GreenKatrina Green, Xu-Feng HuangXu-Feng Huang, K Kang, Chao DengChao Deng

Abstract from the XXVII CINP Congress, 6-10 June 2010, Hong Kong

History

Citation

Weston-Green, K., Huang, X. F., Kang, K. & Deng, C. (2010). Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism. International Journal of Neuropsychopharmacology, 13 (Supplement S1), 111-112.

Journal title

International Journal of Neuropsychopharmacology

Volume

13

Pagination

111-112

Publisher website/DOI

https://doi.org/10.1017/S1461145710000635

Language

English

RIS ID

36764

Usage metrics

Keywords

cb1 receptors hypothalamus brainstem possibly muscarinic m3 receptor antagonism olanzapine decreases cannabinoid

Olanzapine decreases cannabinoid CB1 receptors in the hypothalamus and brainstem, possibly through muscarinic M3 receptor antagonism

History

Citation

Journal title

Volume

Pagination

Publisher website/DOI

Language

RIS ID

Usage metrics

Categories

Keywords

Licence

Exports